BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22605938)

  • 1. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
    Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
    Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.
    Bei YY; Chen XY; Liu Y; Xu JY; Wang WJ; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Wang Q; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1819-27. PubMed ID: 22619530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
    Ding XY; Hong CJ; Liu Y; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1723-35. PubMed ID: 22619523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of cellular uptake and transport mediated by integrin receptor targeting trimethyl chitosan nanoparticles].
    Xu J; Liu C; Xu YN; Shan W; Liu M; Huang Y
    Yao Xue Xue Bao; 2015 Jul; 50(7):893-8. PubMed ID: 26552153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.
    Ke Z; Guo H; Zhu X; Jin Y; Huang Y
    J Pharm Pharm Sci; 2015; 18(2):155-70. PubMed ID: 26158281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation.
    Mi FL; Wu YY; Lin YH; Sonaje K; Ho YC; Chen CT; Juang JH; Sung HW
    Bioconjug Chem; 2008 Jun; 19(6):1248-55. PubMed ID: 18517235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
    Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
    J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives.
    Xu X; Li Y; Shen Y; Guo S
    Int J Biol Macromol; 2013 Nov; 62():418-25. PubMed ID: 24099934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
    Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
    Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
    Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
    Li M; Xu X; Lu F; Guo S
    Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Enhanced Oral Absorption of a Nano-Drug Delivery System Loaded with Trimethyl Chitosan Derivatives.
    Zhao Y; Lin S; Fang R; Shi Y; Wu W; Zhang W; Chen H
    Int J Nanomedicine; 2022; 17():3313-3324. PubMed ID: 35937081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
    J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
    Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
    Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
    Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
    Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.